Published in Scand J Infect Dis on January 01, 2002
Modelling the effectiveness of chlamydia screening in England. Sex Transm Infect (2006) 1.95
A prediction rule for selective screening of Chlamydia trachomatis infection. Sex Transm Infect (2005) 1.61
Implementing chlamydia screening: what do women think? A systematic review of the literature. BMC Public Health (2006) 1.56
Surveillance systems for STIs in the European Union: facing a changing epidemiology. Sex Transm Infect (2004) 1.45
Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. J Infect Dis (2010) 1.38
Developing a realistic sexual network model of chlamydia transmission in Britain. Theor Biol Med Model (2006) 1.22
Chlamydial infection: an accurate model for opportunistic screening in general practice. Sex Transm Infect (2003) 1.03
A TLR2 agonist is a more effective adjuvant for a Chlamydia major outer membrane protein vaccine than ligands to other TLR and NOD receptors. Vaccine (2011) 0.92
Trends in chlamydia and gonorrhea positivity among heterosexual men and men who have sex with men attending a large urban sexual health service in Australia, 2002-2009. BMC Infect Dis (2011) 0.92
Current crisis or artifact of surveillance: insights into rebound chlamydia rates from dynamic modelling. BMC Infect Dis (2010) 0.91
What is the impact of change in diagnostic test method on surveillance data trends in Chlamydia trachomatis infection? Sex Transm Infect (2006) 0.88
Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum. J Immunol (2014) 0.87
Development of a Chlamydia trachomatis T cell Vaccine. Hum Vaccin (2010) 0.87
Management of Chlamydia trachomatis genital tract infection: screening and treatment challenges. Infect Drug Resist (2011) 0.86
A comparison of sexual behaviour and attitudes of healthy adolescents in a Danish high school in 1982, 1996, and 2001. Popul Health Metr (2004) 0.85
Chlamydia trachomatis load in population-based screening and STI-clinics: implications for screening policy. PLoS One (2015) 0.85
Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model. Vaccine (2011) 0.84
Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis. Infect Immun (2013) 0.82
Whole genome identification of C. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques. J Proteomics (2014) 0.81
A vaccine formulated with a combination of TLR-2 and TLR-9 adjuvants and the recombinant major outer membrane protein elicits a robust immune response and significant protection against a Chlamydia muridarum challenge. Microbes Infect (2013) 0.77
A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge. Immunology (2015) 0.76
Update on Chlamydia trachomatis Vaccinology. Clin Vaccine Immunol (2017) 0.75
Comparison of the nine polymorphic membrane proteins of Chlamydia trachomatis for their ability to induce protective immune responses in mice against a C. muridarum challenge. Vaccine (2017) 0.75
A meta-analysis on the effects of antibiotic treatment on duration of symptoms caused by infection with Campylobacter species. Clin Infect Dis (2007) 2.93
Staphylococcus aureus throat colonization is more frequent than colonization in the anterior nares. J Clin Microbiol (2006) 2.61
Is exposure to sick or dead poultry associated with flulike illness?: a population-based study from a rural area in Vietnam with outbreaks of highly pathogenic avian influenza. Arch Intern Med (2006) 2.60
Malaria risk in travelers. Emerg Infect Dis (2005) 1.87
Age- and serogroup-related differences in observed durations of nasopharyngeal carriage of penicillin-resistant pneumococci. J Clin Microbiol (2007) 1.68
The 2000 tularemia outbreak: a case-control study of risk factors in disease-endemic and emergent areas, Sweden. Emerg Infect Dis (2002) 1.58
The comparative burden of salmonellosis in the European Union member states, associated and candidate countries. BMC Public Health (2006) 1.54
Dengue fever in travelers to the tropics, 1998 and 1999. Emerg Infect Dis (2003) 1.50
[Better treatment has reduced AIDS mortality. Increased number of patients with HIV infections will burden the ambulatory care services]. Lakartidningen (2002) 1.40
Timeliness of case reporting in the Swedish statutory surveillance of communicable diseases 1998--2002. Scand J Infect Dis (2004) 1.37
Short- and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis (2008) 1.24
Occurrence of invasive pneumococcal disease and number of excess cases due to influenza. BMC Infect Dis (2006) 1.19
Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology (2005) 1.17
Imported methicillin-resistant Staphylococcus aureus, Sweden. Emerg Infect Dis (2010) 1.16
Effect of regulation and education on reptile-associated salmonellosis. Emerg Infect Dis (2005) 1.13
Serotypes of Streptococcus pneumoniae isolated from blood and cerebrospinal fluid related to vaccine serotypes and to clinical characteristics. Scand J Infect Dis (2006) 1.08
'Did you have flu last week?' A telephone survey to estimate a point prevalence of influenza in the Swedish population. Euro Surveill (2005) 1.08
Hepatitis A risk in travelers. J Travel Med (2009) 1.07
Endemic tularemia, Sweden, 2003. Emerg Infect Dis (2005) 0.99
Children born to HIV-1-infected women in Sweden in 1982-2003: trends in epidemiology and vertical transmission. J Acquir Immune Defic Syndr (2006) 0.99
Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study. J Viral Hepat (2008) 0.96
The epidemiology of hepatitis C virus infection in Sweden. Euro Surveill (2008) 0.93
Serologic analysis of returned travelers with fever, Sweden. Emerg Infect Dis (2009) 0.92
EURISWEB--Web-based epidemiological surveillance of antibiotic-resistant pneumococci in day care centers. BMC Med Inform Decis Mak (2003) 0.89
Mortality following Campylobacter infection: a registry-based linkage study. BMC Infect Dis (2005) 0.89
Epidemiological investigation of a food-borne gastroenteritis outbreak caused by Norwalk-like virus in 30 day-care centres. Scand J Infect Dis (2002) 0.89
Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden 2000-2003, increasing incidence and regional differences. BMC Infect Dis (2006) 0.86
Penicillin-resistant pneumococci in Sweden 1997-2003: increased multiresistance despite stable prevalence and decreased antibiotic use. Microb Drug Resist (2006) 0.86
Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden - a low endemic country. J Viral Hepat (2008) 0.86
Characterization of human invasive isolates of Listeria monocytogenes in Sweden 1986-2007. Foodborne Pathog Dis (2008) 0.85
Reduction in outpatient antibiotic sales for pre-school children: interrupted time series analysis of weekly antibiotic sales data in Sweden 1992-2002. J Antimicrob Chemother (2005) 0.85
Modelling the spread of penicillin-resistant Streptococcus pneumoniae in day-care and evaluation of intervention. Stat Med (2005) 0.84
Implementing a public web based GIS service for feedback of surveillance data on communicable diseases in Sweden. BMC Infect Dis (2004) 0.83
Salmonella-associated deaths, Sweden, 1997-2003. Emerg Infect Dis (2006) 0.83
Travellers returning to Sweden with falciparum malaria: pre-travel advice, behaviour, chemoprophylaxis and diagnostic delay. Scand J Infect Dis (2005) 0.82
Nosocomial pneumonia in the ICU: a prospective cohort study. Scand J Infect Dis (2007) 0.79
Modeling pneumococcal resistance to penicillin in southern Sweden using artificial neural networks. Microb Drug Resist (2006) 0.79
Enhancing the role of health communication in the prevention of infectious diseases. J Health Commun (2013) 0.78
Low rate of pneumococci non-susceptible to penicillin in healthy Swedish toddlers. Scand J Infect Dis (2012) 0.78
The impact of active intervention on the spread of penicillin-resistant Streptococcus pneumoniae in Swedish day-care centres. Scand J Infect Dis (2004) 0.77
Red fox and tick-borne encephalitis (TBE) in humans: can predators influence public health? Scand J Infect Dis (2008) 0.77
H5N1 influenza and the implications for Europe. BMJ (2005) 0.76
Antimicrobial susceptibility of invasive pneumococcal isolates from a region in south-west Sweden 1998-2001. Scand J Infect Dis (2007) 0.76
[ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections]. Lakartidningen (2007) 0.75
Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country. Scand J Gastroenterol (2010) 0.75
[Clothes in health care. Don't mix identification and hygiene routines]. Lakartidningen (2011) 0.75
[HIV in Sweden--more and more part of the world epidemic]. Lakartidningen (2004) 0.75
[Infected abroad--risk factor for late HIV diagnosis]. Lakartidningen (2008) 0.75
[Fewer young people born in Sweden have contracted HIV]. Lakartidningen (2010) 0.75
[Rubella still a problem in Europe--important that pregnant women have an adequate protection]. Lakartidningen (2004) 0.75
[Tonsillitis in young people--consider Fusobacterium necrophorum]. Lakartidningen (2010) 0.75
[A/Fujian--a changeable influenza virus which may cause problems during winter]. Lakartidningen (2003) 0.75
[Good guideline compliance among patients and health services when it comes to suspected SARS infection]. Lakartidningen (2004) 0.75
[Nepropathia epidemica on the increase and spreading south in Sweden]. Lakartidningen (2005) 0.75